Atheart Medical

Atheart Medical company information, Employees & Contact Information

Explore related pages

Related company profiles:

atHeart Medical was founded to establish the first transcatheter septal occluder with a metal-free frame, as the new standard of care for atrial septal defects. We have initiated the U.S. FDA approved ASCENT-ASD pivotal trial in the United States and internationally to demonstrate the safety and efficacy of our reSept ASD Occluder for treating patients with clinically significant, isolated ASD. Our name embeds our values: in everything we do, we have clinical excellence and patients at heart.

Company Details

Employees
20
Founded
-
Address
Bahnhofstrasse 9, Baar,6340,switzerland
Industry
Medical Equipment Manufacturing
NAICS
Medical Equipment and Supplies Manufacturing
Surgical and Medical Instrument Manufacturing
Surgical Appliance and Supplies Manufacturing
Dental Equipment and Supplies Manufacturing
Ophthalmic Goods Manufacturing
Dental Laboratories
HQ
Baar
Looking for a particular Atheart Medical employee's phone or email?

Atheart Medical Questions

News

Newly Formed Company, atHeart Medical, Aims to Evolve Septal Closure with the reSept™ ASD Occluder - PR Newswire

Newly Formed Company, atHeart Medical, Aims to Evolve Septal Closure with the reSept™ ASD Occluder PR Newswire

Bioresorbable ASD Occluder Prepares to Enter U.S. Clinical Trial - Diagnostic and Interventional Cardiology

Bioresorbable ASD Occluder Prepares to Enter U.S. Clinical Trial Diagnostic and Interventional Cardiology

atHeart Medical Receives FDA Approval for the Second Phase of the ASCENT ASD U.S. IDE Trial - PR Newswire

atHeart Medical Receives FDA Approval for the Second Phase of the ASCENT ASD U.S. IDE Trial PR Newswire

Atheart Medical begins IDE trial for septal closure device - BioWorld MedTech

Atheart Medical begins IDE trial for septal closure device BioWorld MedTech

AtHeart Medical reports positive data for ASD occluder with bioresorbable frame - MassDevice

AtHeart Medical reports positive data for ASD occluder with bioresorbable frame MassDevice

atHeart Medical Appoints Seasoned Medtech Executive Andrew Cleeland to Board of Directors - PR Newswire

atHeart Medical Appoints Seasoned Medtech Executive Andrew Cleeland to Board of Directors PR Newswire

First Five Patients Successfully Treated with atHeart Medical's Novel reSept™ Atrial Septal Defect Occluder in U.S. IDE Pivotal Trial - PR Newswire

First Five Patients Successfully Treated with atHeart Medical's Novel reSept™ Atrial Septal Defect Occluder in U.S. IDE Pivotal Trial PR Newswire

Promising long and short-term clinical data show potential of first ASD occluder with a bioresorbable, metal-free frame - PR Newswire

Promising long and short-term clinical data show potential of first ASD occluder with a bioresorbable, metal-free frame PR Newswire

Top Atheart Medical Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant